Protagonist Therapeutics, Inc. (PTGX)
140.06
+0.87
(+0.62%)
USD |
NASDAQ |
Oct 02, 16:00
139.92
-0.14
(-0.10%)
After-Hours: 20:00
Protagonist Therapeutics Price : 140.06 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 140.99 | 141.71 | 138.37 | 140.06 | 760304.0 |
| Oct 01, 2026 | 139.23 | 143.68 | 138.37 | 139.19 | 886246.0 |
| Sep 30, 2026 | 141.60 | 143.74 | 140.44 | 140.89 | 787658.0 |
| Sep 29, 2026 | 143.45 | 144.09 | 138.88 | 140.97 | 508014.0 |
| Sep 28, 2026 | 142.21 | 143.68 | 140.24 | 142.44 | 925462.0 |
| Sep 25, 2026 | 141.81 | 143.45 | 138.23 | 141.86 | 809293.0 |
| Sep 24, 2026 | 138.76 | 140.80 | 134.10 | 137.34 | 989225.0 |
| Sep 23, 2026 | 144.27 | 145.28 | 137.88 | 138.70 | 513226.0 |
| Sep 22, 2026 | 144.64 | 147.71 | 144.50 | 145.07 | 806176.0 |
| Sep 21, 2026 | 143.22 | 145.37 | 141.09 | 144.98 | 822199.0 |
| Sep 18, 2026 | 143.09 | 144.58 | 140.44 | 143.00 | 1.837M |
| Sep 17, 2026 | 144.39 | 146.50 | 142.31 | 143.70 | 558901.0 |
| Sep 16, 2026 | 144.19 | 146.19 | 140.88 | 142.84 | 507312.0 |
| Sep 15, 2026 | 147.48 | 147.99 | 142.00 | 143.40 | 637522.0 |
| Sep 14, 2026 | 150.23 | 151.24 | 146.83 | 147.78 | 608017.0 |
| Sep 11, 2026 | 147.18 | 150.48 | 145.82 | 148.18 | 478038.0 |
| Sep 10, 2026 | 143.29 | 146.51 | 142.00 | 145.16 | 543130.0 |
| Sep 09, 2026 | 146.05 | 151.18 | 144.46 | 145.09 | 530534.0 |
| Sep 08, 2026 | 143.61 | 147.29 | 142.00 | 145.94 | 700126.0 |
| Sep 04, 2026 | 146.47 | 147.99 | 144.01 | 145.72 | 501305.0 |
| Sep 03, 2026 | 146.68 | 149.49 | 144.00 | 148.80 | 354191.0 |
| Sep 02, 2026 | 148.00 | 149.42 | 144.61 | 146.08 | 561612.0 |
| Sep 01, 2026 | 147.75 | 150.34 | 144.72 | 146.49 | 534144.0 |
| Aug 31, 2026 | 143.26 | 149.30 | 141.95 | 147.75 | 567396.0 |
| Aug 28, 2026 | 147.73 | 147.95 | 142.43 | 144.33 | 501248.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 262.82 |
| Gilead Sciences, Inc. | 144.74 |
| Johnson & Johnson | 256.03 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| BioMarin Pharmaceutical, Inc. | 57.18 |
Price Related Metrics
| PE Ratio | 135.06 |
| PS Ratio | 33.44 |
| PEG Ratio | 2.966 |
| Price to Book Value | 10.76 |
| Price to Free Cash Flow | 72.21 |
| Earnings Yield | 0.74% |
| Market Cap | 9.058B |
| PEGY Ratio | 2.966 |
| Operating PE Ratio | 161.63 |
| Normalized PE Ratio | 135.05 |